AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 32205036 — intervention group
Group type: EXPERIMENTAL
Intervention: Automated spirit presence and communication technology (total hardware cost per system less than $4,000)
Number of subjects: 0
Study 34318607 — intervention group
Group type: EXPERIMENTAL
Intervention: Sovesudil 0.5% TID
Number of subjects: 119
Study 34318607 — intervention group
Group type: EXPERIMENTAL
Intervention: Sovesudil 0.25% TID
Number of subjects: 119
Study 34318607 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 119
Study 34318607 — intervention group
Group type: COMPARATOR
Intervention: Sovesudil 0.5% TID vs Placebo
Number of subjects: 119
Study 34318607 — intervention group
Group type: EXPERIMENTAL
Intervention: Sovesudil (both doses)
Number of subjects: 119
Study 33780901 — intervention group
Group type: EXPERIMENTAL
Intervention: Bolgerization
Number of subjects: 41
Study 33780901 — intervention group
Group type: COMPARATOR
Intervention: Partial resection
Number of subjects: 41
Study 33159373 — intervention group
Group type: EXPERIMENTAL
Intervention: PTSD Coach Online-Arabic
Number of subjects: 87
Study 36472309 — intervention group
Group type: EXPERIMENTAL
Intervention: Mandibular advancement device (MAD)
Number of subjects: 0
Study 36472309 — intervention group
Group type: COMPARATOR
Intervention: New 'boil and bite' MAD
Number of subjects: 0
Study 36472309 — intervention group
Group type: COMPARATOR
Intervention: Custom MAD
Number of subjects: 0
Study 34632925 — intervention group
Group type: EXPERIMENTAL
Intervention: Dolcanatide 27 mg daily for 7 days
Number of subjects: 0
Study 34632925 — intervention group
Group type: COMPARATOR
Intervention: Placebo (implied control)
Number of subjects: 0
Study 32056528 — intervention group
Group type: EXPERIMENTAL
Intervention: 70% sterile honey‐based ophthalmic formulation
Number of subjects: 50
Study 32056528 — intervention group
Group type: COMPARATOR
Intervention: 0.3% ophthalmic ciprofloxacin
Number of subjects: 50
Study 33080740 — intervention group
Group type: EXPERIMENTAL
Intervention: IV lidocaine at 1.5 mg/kg
Number of subjects: 138
Study 33080740 — intervention group
Group type: COMPARATOR
Intervention: Normal saline (control)
Number of subjects: 138
Study 35857170 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical pilates exercises for 6 weeks
Number of subjects: 50
Study 35857170 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical pilates exercises
Number of subjects: 50
Study 35857170 — intervention group
Group type: COMPARATOR
Intervention: Control group (posture education)
Number of subjects: 50
Study 33340153 — intervention group
Group type: EXPERIMENTAL
Intervention: DE graft (DE+)
Number of subjects: 60
Study 33340153 — intervention group
Group type: EXPERIMENTAL
Intervention: PI graft (PI+)
Number of subjects: 60
Study 32585425 — intervention group
Group type: EXPERIMENTAL
Intervention: Skidmore Anxiety Stigma Scale (SASS)
Number of subjects: 270
Study 34407441 — intervention group
Group type: EXPERIMENTAL
Intervention: Nigella sativa oil (NSO) 500 mg twice daily for 10 days
Number of subjects: 173
Study 34407441 — intervention group
Group type: COMPARATOR
Intervention: Control group (usual care)
Number of subjects: 173
Study 34407441 — intervention group
Group type: EXPERIMENTAL
Intervention: Nigella sativa oil (NSO)
Number of subjects: 173
Study 33272080 — intervention group
Group type: EXPERIMENTAL
Intervention: Attune total knee replacement
Number of subjects: 42
Study 34800794 — intervention group
Group type: COMPARATOR
Intervention: dHACM Sheet
Number of subjects: 40
Study 34800794 — intervention group
Group type: COMPARATOR
Intervention: dHACM Injection
Number of subjects: 40
Study 34800794 — intervention group
Group type: COMPARATOR
Intervention: No Treatment
Number of subjects: 40
Study 34800794 — intervention group
Group type: COMPARATOR
Intervention: Saline
Number of subjects: 40
Study 34800794 — intervention group
Group type: EXPERIMENTAL
Intervention: dHACM-treated animals
Number of subjects: 40
Study 33798297 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural labor analgesia
Number of subjects: 120
Study 33798297 — intervention group
Group type: EXPERIMENTAL
Intervention: TEAS combined with epidural labor analgesia
Number of subjects: 120
Study 33798297 — intervention group
Group type: COMPARATOR
Intervention: Control group (no labor analgesia)
Number of subjects: 120
Study 33798297 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural group
Number of subjects: 120
Study 33798297 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination group (TEAS + epidural)
Number of subjects: 120
Study 32538733 — intervention group
Group type: EXPERIMENTAL
Intervention: Risk minimization measures
Number of subjects: 154
Study 33825333 — intervention group
Group type: EXPERIMENTAL
Intervention: Foam and cream for rosacea patients (verum)
Number of subjects: 33
Study 33825333 — intervention group
Group type: COMPARATOR
Intervention: Vehicle (control)
Number of subjects: 33
Study 33098300 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive performance measured with the Brief Assessment of Cognition in Schizophrenia
Number of subjects: 767
Study 33098300 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive profiles
Number of subjects: 767
Study 33098300 — intervention group
Group type: EXPERIMENTAL
Intervention: Latent transition analysis
Number of subjects: 767
Study 33098300 — intervention group
Group type: EXPERIMENTAL
Intervention: Confirmatory factor analysis (CFA)
Number of subjects: 767
Study 33098300 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive subtyping
Number of subjects: 767
Study 32078025 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment of body-focused repetitive behaviors
Number of subjects: 166
Study 36469926 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin
Number of subjects: 0
Study 36469926 — intervention group
Group type: COMPARATOR
Intervention: Enoxaparin
Number of subjects: 0
Study 34221475 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational support programme
Number of subjects: 80
Study 34221475 — intervention group
Group type: COMPARATOR
Intervention: Routine care
Number of subjects: 80
Study 32178526 — intervention group
Group type: EXPERIMENTAL
Intervention: DPI (rivaroxaban 2.5 mg twice daily plus aspirin 100 mg once daily)
Number of subjects: 16560
Study 32178526 — intervention group
Group type: COMPARATOR
Intervention: Aspirin (100 mg once daily)
Number of subjects: 16560
Study 35849139 — intervention group
Group type: EXPERIMENTAL
Intervention: Telehealth diabetes prevention lifestyle program (13 telephone sessions and behavior change techniques)
Number of subjects: 1087
Study 35849139 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavior change techniques (BCTs)
Number of subjects: 1087
Study 35849139 — intervention group
Group type: EXPERIMENTAL
Intervention: Goal setting for weight management
Number of subjects: 1087
Study 35849139 — intervention group
Group type: EXPERIMENTAL
Intervention: Perceived success in reaching a healthy weight
Number of subjects: 1087
Study 33249458 — intervention group
Group type: EXPERIMENTAL
Intervention: Varenicline sampling
Number of subjects: 99
Study 34155411 — intervention group
Group type: EXPERIMENTAL
Intervention: gantenerumab
Number of subjects: 144
Study 34155411 — intervention group
Group type: EXPERIMENTAL
Intervention: solanezumab
Number of subjects: 144
Study 34155411 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 144
Study 36327436 — intervention group
Group type: EXPERIMENTAL
Intervention: HTD1801 500 mg BID
Number of subjects: 55
Study 36327436 — intervention group
Group type: EXPERIMENTAL
Intervention: HTD1801 1000 mg BID
Number of subjects: 55
Study 36327436 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 55
Study 32151562 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 mg lactoferrin
Number of subjects: 310
Study 32151562 — intervention group
Group type: EXPERIMENTAL
Intervention: 600 mg lactoferrin
Number of subjects: 310
Study 32151562 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 310
Study 36215873 — intervention group
Group type: EXPERIMENTAL
Intervention: Couple-based interpersonal psychotherapy (IPT)
Number of subjects: 455
Study 36215873 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 455
Study 33950222 — intervention group
Group type: EXPERIMENTAL
Intervention: Anodal cerebellar tDCS and cathodal spinal tDCS (real tDCS)
Number of subjects: 61
Study 33950222 — intervention group
Group type: COMPARATOR
Intervention: Sham tDCS
Number of subjects: 61
Study 32144049 — intervention group
Group type: EXPERIMENTAL
Intervention: Grade 3 recurrence
Number of subjects: 472
Study 32144049 — intervention group
Group type: EXPERIMENTAL
Intervention: Grade 3 progression
Number of subjects: 472
Study 32144049 — intervention group
Group type: EXPERIMENTAL
Intervention: NMIBC patients
Number of subjects: 472
Study 32144049 — intervention group
Group type: EXPERIMENTAL
Intervention: Grade 1 recurrence
Number of subjects: 472
Study 32144049 — intervention group
Group type: EXPERIMENTAL
Intervention: Grade 2 recurrence
Number of subjects: 472
Study 32144049 — intervention group
Group type: EXPERIMENTAL
Intervention: Progression to MIBC
Number of subjects: 472
Study 34752990 — intervention group
Group type: EXPERIMENTAL
Intervention: Igual-Mente program (education, contact, skill development)
Number of subjects: 316
Study 34752990 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 316
Study 34752990 — intervention group
Group type: EXPERIMENTAL
Intervention: Humane treatment behaviors
Number of subjects: 316
Study 33607121 — intervention group
Group type: EXPERIMENTAL
Intervention: 8.25% Sodium Hypochlorite (NaOCl)
Number of subjects: 180
Study 33607121 — intervention group
Group type: COMPARATOR
Intervention: 2.5% Sodium Hypochlorite (NaOCl)
Number of subjects: 180
Study 33607121 — intervention group
Group type: COMPARATOR
Intervention: 5.25% Sodium Hypochlorite (NaOCl)
Number of subjects: 180
Study 33607121 — intervention group
Group type: COMPARATOR
Intervention: 2% Chlorhexidine (CHX)
Number of subjects: 180
Study 33607121 — intervention group
Group type: EXPERIMENTAL
Intervention: Preparation time ≥10 minutes
Number of subjects: 180
Study 33607121 — intervention group
Group type: EXPERIMENTAL
Intervention: Overfilling
Number of subjects: 180
Study 32899001 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine
Number of subjects: 80
Study 32899001 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 80
Study 35034712 — intervention group
Group type: EXPERIMENTAL
Intervention: Computerized intervention
Number of subjects: 300
Study 35034712 — intervention group
Group type: COMPARATOR
Intervention: Control (healthy comparisons)
Number of subjects: 300
Study 33092501 — intervention group
Group type: EXPERIMENTAL
Intervention: Granulocyte colony-stimulating factor (G-CSF) administered via continuous intravenous infusion at a dosage of 90 μg/kg
Number of subjects: 0
Study 33092501 — intervention group
Group type: COMPARATOR
Intervention: Normal saline (placebo)
Number of subjects: 0
Study 35330880 — intervention group
Group type: EXPERIMENTAL
Intervention: Short Flex (8 ± 2 weeks)
Number of subjects: 282
Study 35330880 — intervention group
Group type: COMPARATOR
Intervention: Long Flex (14 ± 2 weeks)
Number of subjects: 282
Study 35330880 — intervention group
Group type: EXPERIMENTAL
Intervention: Short Flex
Number of subjects: 282
Study 35330880 — intervention group
Group type: EXPERIMENTAL
Intervention: Short Flex and Long Flex
Number of subjects: 282
Study 36126211 — intervention group
Group type: EXPERIMENTAL
Intervention: Defect bridging of the sural nerve with a venous graft
Number of subjects: 34
Study 36126211 — intervention group
Group type: COMPARATOR
Intervention: No nerve reconstruction (Control)
Number of subjects: 34
Study 34092117 — intervention group
Group type: EXPERIMENTAL
Intervention: Tailored rehabilitation nursing care program (RNT)
Number of subjects: 80
Study 34092117 — intervention group
Group type: COMPARATOR
Intervention: Treatment as Usual (TAU)
Number of subjects: 80
Study 35184572 — intervention group
Group type: EXPERIMENTAL
Intervention: SBP-drop (defined as SBP<100 mm Hg or a drop from baseline of 40 mm Hg)
Number of subjects: 11226
Study 35184572 — intervention group
Group type: EXPERIMENTAL
Intervention: SBP<100 mm Hg
Number of subjects: 11226
Study 35184572 — intervention group
Group type: EXPERIMENTAL
Intervention: 40 mm Hg drop
Number of subjects: 11226
Study 35184572 — intervention group
Group type: COMPARATOR
Intervention: Placebo group with SBP-drop
Number of subjects: 11226
Study 35184572 — intervention group
Group type: EXPERIMENTAL
Intervention: Serelaxin group with SBP-drop
Number of subjects: 11226
Study 34932665 — intervention group
Group type: EXPERIMENTAL
Intervention: OHES (caries‐free)
Number of subjects: 93
Study 34932665 — intervention group
Group type: EXPERIMENTAL
Intervention: ART (dental caries)
Number of subjects: 93
Study 34932665 — intervention group
Group type: EXPERIMENTAL
Intervention: ART plus OHES (dental caries)
Number of subjects: 93
Study 35895867 — intervention group
Group type: EXPERIMENTAL
Intervention: sacubitril/valsartan
Number of subjects: 2306
Study 35895867 — intervention group
Group type: COMPARATOR
Intervention: valsartan
Number of subjects: 2306
Study 35895867 — intervention group
Group type: EXPERIMENTAL
Intervention: Post-randomization HF hospitalization
Number of subjects: 2306
Study 35895867 — intervention group
Group type: EXPERIMENTAL
Intervention: 12 months preceding HF hospitalization
Number of subjects: 2306
Study 35895867 — intervention group
Group type: EXPERIMENTAL
Intervention: 12 months following hospitalization
Number of subjects: 2306
Study 33096120 — intervention group
Group type: EXPERIMENTAL
Intervention: Grape juice group (GJG) consuming 400 ml of grape juice per day for 1 month
Number of subjects: 29
Study 33096120 — intervention group
Group type: COMPARATOR
Intervention: Placebo and exercise group (PLEG) with concurrent physical training
Number of subjects: 29
Study 33096120 — intervention group
Group type: EXPERIMENTAL
Intervention: Grape juice and exercise group (GJEG) with concurrent physical training
Number of subjects: 29
Study 33096120 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical training protocol (for PLEG and GJEG)
Number of subjects: 29
Study 33096120 — intervention group
Group type: EXPERIMENTAL
Intervention: Grape juice group (GJG) without exercise
Number of subjects: 29
Study 33096120 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups (GJG, PLEG, GJEG)
Number of subjects: 29
Study 33426861 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotic mixture (Abincol) containing Lactobacillus plantarum LP01 (1 billion of living cells), Lactobacillus lactis subspecies cremoris LLC02 (800 million of living cells), and Lactobacillus delbrueckii subspecies delbrueckii LDD01 (200 million of living cells) for one month.
Number of subjects: 1118
Study 33426861 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotic mixture (Abincol) for one month.
Number of subjects: 1118
Study 33426861 — intervention group
Group type: COMPARATOR
Intervention: No add-on treatment (Group B).
Number of subjects: 1118
Study 34582657 — intervention group
Group type: EXPERIMENTAL
Intervention: Zinc Supplement (45 mg of elemental zinc for 12 weeks)
Number of subjects: 69
Study 34582657 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 69
Study 33109094 — intervention group
Group type: EXPERIMENTAL
Intervention: Dialysate at a controlled temperature of 37 °C
Number of subjects: 18
Study 33109094 — intervention group
Group type: COMPARATOR
Intervention: Dialysate warmed with conventional methods
Number of subjects: 18
Study 36228016 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance training with equalized total training volume (RTEV)
Number of subjects: 24
Study 36228016 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance training with unequalized total training volume (RTUV)
Number of subjects: 24
Study 36228016 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance training performed three times a week
Number of subjects: 24
Study 36228016 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance training performed once a week
Number of subjects: 24
Study 36228016 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher RT frequency (RTUV)
Number of subjects: 24
Study 33883008 — intervention group
Group type: EXPERIMENTAL
Intervention: HTL0018318 (15–35 mg/day)
Number of subjects: 86
Study 33883008 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 86
Study 32757725 — intervention group
Group type: EXPERIMENTAL
Intervention: Sitting Workstation
Number of subjects: 40
Study 32757725 — intervention group
Group type: COMPARATOR
Intervention: Standing Workstation
Number of subjects: 40
Study 36034730 — intervention group
Group type: EXPERIMENTAL
Intervention: Sacroiliac belt
Number of subjects: 0
Study 36034730 — intervention group
Group type: COMPARATOR
Intervention: Lumbar orthosis
Number of subjects: 0
Study 32516410 — intervention group
Group type: EXPERIMENTAL
Intervention: HiOxy (packaged for 24 h in 80% O2)
Number of subjects: 36
Study 32516410 — intervention group
Group type: EXPERIMENTAL
Intervention: HiOxy (4 d aging)
Number of subjects: 36
Study 32516410 — intervention group
Group type: EXPERIMENTAL
Intervention: HiOxy (20 d aging, 6 mo storage)
Number of subjects: 36
Study 32516410 — intervention group
Group type: EXPERIMENTAL
Intervention: HiOxy
Number of subjects: 36
Study 32516410 — intervention group
Group type: EXPERIMENTAL
Intervention: DeOxy
Number of subjects: 36
Study 32516410 — intervention group
Group type: EXPERIMENTAL
Intervention: HiOxy (2, 4, and 6 mo storage)
Number of subjects: 36
Study 33974991 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4925
Study 33554323 — intervention group
Group type: EXPERIMENTAL
Intervention: Platelet-rich fibrin (PRF) membrane
Number of subjects: 27
Study 33554323 — intervention group
Group type: COMPARATOR
Intervention: Deproteinised bovine bone mineral and a resorbable collagen membrane (control group)
Number of subjects: 27
Study 32598663 — intervention group
Group type: EXPERIMENTAL
Intervention: Blood pressure telemonitoring and distant counseling (BPTM)
Number of subjects: 240
Study 32598663 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 240
Study 34247295 — intervention group
Group type: EXPERIMENTAL
Intervention: Robotic rehabilitation group (RR) - 30–45 min, 5 days per week for 4 weeks
Number of subjects: 37
Study 34247295 — intervention group
Group type: EXPERIMENTAL
Intervention: Robotic rehabilitation group (RR)
Number of subjects: 37
Study 34247295 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 37
Study 34174217 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose pitavastatin 4mg
Number of subjects: 12008
Study 34174217 — intervention group
Group type: COMPARATOR
Intervention: Low-dose pitavastatin 1mg
Number of subjects: 12008
Study 35481595 — intervention group
Group type: EXPERIMENTAL
Intervention: Cavitation and radiofrequency plus dietary regimen
Number of subjects: 60
Study 35481595 — intervention group
Group type: EXPERIMENTAL
Intervention: Cryolipolysis plus dietary regimen
Number of subjects: 60
Study 35481595 — intervention group
Group type: COMPARATOR
Intervention: Dietary regimen only
Number of subjects: 60
Study 33888596 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicotinamide mononucleotide (NMN) supplementation
Number of subjects: 0
Study 33888596 — intervention group
Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 0
Study 33658990 — intervention group
Group type: EXPERIMENTAL
Intervention: Crude peanut-extract (CPE) + Fructo-Oligosaccharides (FF)
Number of subjects: 0
Study 33658990 — intervention group
Group type: COMPARATOR
Intervention: Crude peanut-extract (CPE)
Number of subjects: 0
Study 33658990 — intervention group
Group type: EXPERIMENTAL
Intervention: CPE-matDCs with FF
Number of subjects: 0
Study 33658990 — intervention group
Group type: COMPARATOR
Intervention: CPE-matDCs
Number of subjects: 0
Study 36244610 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group
Number of subjects: 114
Study 36244610 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 114
Study 33849582 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-based visits with a peer supporter over a six month period, plus standard care
Number of subjects: 20
Study 33849582 — intervention group
Group type: COMPARATOR
Intervention: Standard care only
Number of subjects: 20
Study 33439266 — intervention group
Group type: EXPERIMENTAL
Intervention: Prostate radiation therapy (PRT) added to androgen deprivation therapy (ADT)
Number of subjects: 10000
Study 33439266 — intervention group
Group type: COMPARATOR
Intervention: Androgen deprivation therapy (ADT) alone
Number of subjects: 10000
Study 32829608 — intervention group
Group type: EXPERIMENTAL
Intervention: Silver ion dressing
Number of subjects: 90
Study 32829608 — intervention group
Group type: COMPARATOR
Intervention: Sterile dressing
Number of subjects: 90
Study 32829608 — intervention group
Group type: COMPARATOR
Intervention: Anerdian dressing
Number of subjects: 90
Study 33502326 — intervention group
Group type: EXPERIMENTAL
Intervention: Smartphone-based mindfulness training (self-guided, 8-week duration)
Number of subjects: 168
Study 33502326 — intervention group
Group type: EXPERIMENTAL
Intervention: Smartphone-based mindfulness training
Number of subjects: 168
Study 33502326 — intervention group
Group type: EXPERIMENTAL
Intervention: Smartphone-based mindfulness training (for nulliparous women)
Number of subjects: 168
Study 34344312 — intervention group
Group type: EXPERIMENTAL
Intervention: Healthy Patterns intervention (home-based activity intervention)
Number of subjects: 200
Study 32173165 — intervention group
Group type: EXPERIMENTAL
Intervention: Cartoon-assisted preparation package for endoscopy
Number of subjects: 65
Study 32173165 — intervention group
Group type: COMPARATOR
Intervention: Control group (standard preparation)
Number of subjects: 65
Study 35357323 — intervention group
Group type: EXPERIMENTAL
Intervention: Personalized treatment that tailored complexity parameters based on participants' self-reported capabilities and goals
Number of subjects: 0
Study 35357323 — intervention group
Group type: COMPARATOR
Intervention: Control treatment with complexity parameters set generically based on national guidelines
Number of subjects: 0
Study 35357323 — intervention group
Group type: EXPERIMENTAL
Intervention: Personalization of suggested ride duration
Number of subjects: 0
Study 35357323 — intervention group
Group type: EXPERIMENTAL
Intervention: Personalization of sports session frequency
Number of subjects: 0
Study 33939311 — intervention group
Group type: EXPERIMENTAL
Intervention: Gingival recession (REC) assessment
Number of subjects: 104
Study 33939311 — intervention group
Group type: EXPERIMENTAL
Intervention: Gingival bleeding index (GBI) assessment
Number of subjects: 104
Study 35164865 — intervention group
Group type: EXPERIMENTAL
Intervention: Teaching Recovery Techniques (TRT)
Number of subjects: 15
Study 35164865 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control
Number of subjects: 15